Brief: Ocuphire Pharma Q2 revenue USD 3.674 million
11/08/2023 13:13
Aug 11 (Reuters) - Ocuphire Pharma Q2 net income USD -4.961 million. * Q2 operating expenses USD 9.063 million * Q2 pretax profit USD -4.961 million * Q2 operating income USD -5.389 million * Q2 revenue USD 3.674 million
Recent news on Opus Genetics
See all newsUS RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Health Rounds: Experimental eye drops ease night vision problems for drivers
U.S. STOCKS ON THE MOVE-Apple, Omnicom, Jersey Mike's Subs
U.S. STOCKS ON THE MOVE-Airbnb, Lyft, Korn Ferry
Opus Genetics hits 5-year high on positive early- to mid-stage eye disease gene therapy data